COASTAL PHYSICIAN GROUP INC
DEFA14A, 1996-09-04
HELP SUPPLY SERVICES
Previous: ICON CASH FLOW PARTNERS L P SERIES D, 8-K, 1996-09-04
Next: SMITH BARNEY SERIES FUND, PRES14A, 1996-09-04









                                   SCHEDULE 14A
                                  (Rule 14a-101)
                     INFORMATION REQUIRED IN PROXY STATEMENT
                             SCHEDULE 14A INFORMATION

                    Proxy Statement Pursuant to Section 14(a)
                      of the Securities Exchange Act of 1934


         Filed by the Registrant  [x]
         Filed by a Party other than the Registrant  [ ]

         Check the appropriate box:
         [ ]  Preliminary Proxy Statement
         [ ]  Confidential, for Use of the Commission Only (as permitted
              by Rule 14a-6(c)(2))
         [ ]  Definitive Proxy Statement
         [ ]  Definitive Additional Materials
         [X]  Soliciting Material Pursuant to Section 240.14a-11(c) or
              Section 240.14a-12


                          Coastal Physician Group, Inc.

                 (Name of Registrant as Specified In Its Charter)

                          Coastal Physician Group, Inc.

                    (Name of Person(s) Filing Proxy Statement)

         Payment of Filing Fee (Check the appropriate box):

         [ ]  $125 per Exchange Act Rules 0-11(c)(1)(ii), 14a-6(i)(1),
              14a-6(i)(2) or item 22(a)(2) of Schedule 14A.
         [ ]  $500 per each party to the controversy pursuant to
              Exchange Act Rule 14a-6(i)(3).
         [ ]  Fee computed on table below per Exchange Act Rules 14a-
              6(i)(4) and 0-11.

              (1)  Title of each class of securities to which
                   transaction applies:

              (2)  Aggregate number of securities to which transaction
                   applies:

              (3)  Per unit price or other underlying value of
                   transaction computed pursuant to Exchange Act Rule 0-
                   11:

              (4)  Proposed maximum aggregate value of transaction:

              (5)  Total fee paid:

         [X]  Fee paid previously with preliminary materials.<PAGE>





         [ ]  Check box if any part of the fee is offset as provided by
              Exchange Act Rule 0-11(a)(2) and identify the filing for
              which the offsetting fee was paid previously.  Identify
              the previous filing by registration statement number, or
              the Form or Schedule and the date of its filing.

              (1)  Amount Previously Paid:

              (2)  Form, Schedule or Registration Statement No.:

              (3)  Filing Party:

              (4)  Date Filed:<PAGE>





                       [LOGO COASTAL PHYSICIAN GROUP, INC.]
                              2828 Croasdaile Drive
                          Durham, North Carolina  27705


                                            September 4, 1996

         DEAR SHAREHOLDER:

              You have recently received a letter from Dr. Steven Scott,
         who is seeking your support to elect his hand-picked nominees
         to the Coastal Board in opposition to your management's
         candidates at Coastal's upcoming Annual Meeting, currently
         scheduled for Friday, September 27.

               DON'T BE FOOLED. THE REAL ISSUE IS WHO CAN YOU TRUST
                   TO BEST RESTORE VALUE FOR ALL SHAREHOLDERS.

              In our view, Dr. Scott's letter is merely a transparent
         ploy to mislead you about Company expenses for consultants
         Price Waterhouse and employment contracts for Chairman Jacque
         Sokolov, M.D., CEO Joseph Piemont, and CFO Steven Corman.  WE
         BELIEVE HIS LETTER IS NOTHING MORE THAN A THINLY-VEILED ATTEMPT
         TO WIN YOUR VOTE BY DIVERTING YOUR ATTENTION FROM THE REAL
         ISSUE IN THIS ELECTION CONTEST.  THAT IS:  WHO CAN YOU TRUST TO
         RESTORE AND DELIVER MAXIMUM SHARE VALUE FOR THE BENEFIT OF ALL
         SHAREHOLDERS?

          REJECT STEVEN SCOTT WHO LOST MORE THAN HALF A BILLION DOLLARS
           IN SHAREHOLDER VALUE -- AN 80% DECREASE FROM COASTAL'S PEAK.

              STEVEN SCOTT WAS AT COASTAL'S HELM DURING THE COMPANY'S
         PERIOD OF DISMAL FINANCIAL PERFORMANCE IN WHICH YOUR INVESTMENT
         LOST ABOUT 80% OF ITS VALUE FROM COASTAL'S PEAK STOCK PRICE OF
         $40.25, REPRESENTING APPROXIMATELY $575,000,000 IN LOST
         SHAREHOLDER VALUE.

              The following graph dramatically shows the Company's
         miserable stock price performance from its January 31, 1994
         peak until Dr. Scott was placed on leave on May 29, 1996:

                         January 31, 1994 - May 29, 1996
                       Coastal Physician Group Stock Price*

                         (Performance Graph Appears Here)

               Date     Last Sales Price     Date     Last Sales Price

               1/94          40 1/4          4/95          15 5/8
               2/94          36 1/4          5/95          15 5/8
               3/94          33 1/2          6/95          12 7/8
               4/94          32 5/8          7/95          14 1/8
               5/94          35              8/95          15 1/8<PAGE>





               6/94          33 3/4          9/95          17 1/2
               7/94          34 1/2         10/95          13 1/8
               8/94          34 1/2         11/95          14 1/8
               9/94          32 3/4         12/95          13 1/2
              10/94          31 1/2          1/96          11 7/8
              11/94          32 1/4          2/96          13   
              12/94          27 3/8          3/96           8 7/8
               1/95          25              4/96           8 3/8
               2/95          26              5/96           7 7/8
               3/95          27 1/4

              *  Each data point represents Coastal's last sale price on
              the last trading day of the corresponding month and year,
              except for the final point which represents Wednesday, May
              29, 1996.


              Coastal's stock price decline was so swift and Dr. Scott's
         apparent inability to address this deteriorating situation so
         shocking that the Board determined it had no choice but to
         place Dr. Scott on leave in order to help procure a credit
         facility and resolve conflicts at the executive level.

              ASK YOURSELF:  DO YOU REALLY WANT, BY ELECTING DR. SCOTT'S
         HAND-PICKED CANDIDATES, TO RETURN CONTROL OF YOUR COMPANY TO
         THE SAME MAN WHO PRESIDED OVER THIS DISASTROUS PLUNGE IN THE
         COMPANY'S VALUE?  WE THINK THE ANSWER IS CLEARLY NO.

              DR. SCOTT NEGLECTS TO TELL YOU THAT HE NEGOTIATED ALL 
               BUT ONE OF THE AGREEMENTS ABOUT WHICH HE COMPLAINS.

              Furthermore, although Dr. Scott's letter complains about
         the cost of Price Waterhouse and two senior executives, it
         neglects to tell you that, as Chief Executive Officer:

              -    Steven Scott negotiated and voted to approve the
                   Price Waterhouse contract.

              -    Steven Scott negotiated and voted to approve Dr.
                   Sokolov's employment contract.

              -    Steven Scott negotiated and voted to approve Mr.
                   Corman's employment contract.

              YOU SHOULD KNOW THAT STEVEN SCOTT CONTINUES TO RECEIVE
         $400,000 ANNUALLY FROM THE COMPANY EVEN THOUGH HE NEITHER HOLDS
         AN EXECUTIVE POSITION NOR PERFORMS ANY SERVICES FOR THE
         COMPANY.  HE HAS ALSO DEMANDED $2.1 MILLION IN SEVERANCE PAY
         FROM THE COMPANY.

              Dr. Scott also complains about Mr. Piemont's compensation,
         but remember -- it was Dr. Scott who originally recruited Mr.
         Piemont to Coastal and later promoted him to Executive Vice<PAGE>





         President.  Dr. Scott also recommended Mr. Piemont for the
         President's position.

              Dr. Scott also fails to note that the retention of Price
         Waterhouse would not have been necessary if the Company's
         financial performance had not failed so rapidly under Dr.
         Scott's stewardship.  Again, it was our lenders who urged us to
         hire such a consultant to provide advice and oversight for
         overcoming the Company's problems.

              Moreover, Dr. Scott's proxy fight -- which has made the
         operational turnaround even more difficult -- has forced the
         Company to require Price Waterhouse's services even more.

              IN OUR VIEW, STEVEN SCOTT SURELY HAS NO ONE TO BLAME BUT
         HIMSELF FOR THE COSTS INCURRED TO CLEAN UP THE FINANCIAL MESS
         HE CREATED.

          DECIDE FOR YOURSELF HOW INDEPENDENT DR. SCOTT'S NOMINEES ARE.

              Steven Scott thinks his two hand-picked candidates, the
         two current directors who are his staunch supporters, and he
         himself -- who together would comprise a five director majority
         on Coastal's nine seat Board -- are best qualified to move
         Coastal forward.  We sharply disagree and believe you will,
         too, once you examine who they are, their conflicts of interest
         and the extent of their personal loyalty to Dr. Scott.

              -    SCOTT NOMINEE MITCHELL W. BERGER IS AN ATTORNEY WHOSE
                   FIRM HAS REPRESENTED DR. SCOTT ON NUMEROUS PERSONAL
                   MATTERS, INCLUDING CERTAIN REAL ESTATE MATTERS
                   AGAINST SUBSIDIARIES OF THE COMPANY.  FOR EXAMPLE,
                   MR. BERGER'S FIRM REPRESENTED AN ENTITY DR. SCOTT
                   CONTROLLED, CORAL RIDGE PROPERTY LAND TRUST, AS
                   LANDLORD TO SUBSIDIARIES OF THE COMPANY.  IN FACT,
                   MR. BERGER HAS SERVED AS TRUSTEE TO THIS ENTITY AND
                   HE IS THEREFORE NAMED AS LANDLORD ON THE EXECUTED
                   LEASE.

              -    Current director and Scott supporter Dr. Bertram
                   Walls was a medical resident at Duke University with
                   Dr. Scott.  Later, Dr. Walls joined Dr. Scott in a
                   private medical practice.  He serves as trustee for
                   certain trusts for Dr. Scott's children.

              -    DR. WALLS IS ALSO PRESIDENT OF CENTURY AMERICAN
                   INSURANCE GROUP, A FIRM 100% OWNED BY DR. SCOTT,
                   WHICH VIRTUALLY HAS NO OTHER PURPOSE THAN TO ACT AS
                   COASTAL'S INSURER.  CURRENT PREMIUMS PAID BY COASTAL
                   AND COASTAL PHYSICIANS ARE IN THE AGGREGATE GREATER
                   THAN $20 MILLION PER YEAR.  CURRENTLY, DR. WALLS IS
                   SEEKING AN UNPRECEDENTED FIVE YEAR CONTRACT FOR
                   CENTURY WITH COASTAL ON DR. SCOTT'S BEHALF.<PAGE>





              -    Another Scott nominee, Henry Murphy, is a retired
                   accountant personally selected by Dr. Scott, but with
                   no disclosed experience in the health care field.

              -    Current director John A. Hemingway also has a long-
                   standing relationship with Dr. Scott.  Following his
                   removal as Secretary of the Company and as President
                   of Coastal Physician Services -- actions to which Dr.
                   Scott strongly objected -- Hemingway claimed that he
                   had in effect been terminated by the Company.

              -    AS A RESULT, MR. HEMINGWAY DEMANDED A LUMP-SUM
                   PAYMENT OF NEARLY FIVE MONTHS' SALARY, PLUS
                   CONTINUING COMPENSATION TOTALING $1 MILLION, PAYABLE
                   IN EQUAL INSTALLMENTS OVER A FIVE YEAR PERIOD.  HE
                   CLAIMED THIS WAS PROMISED TO HIM IN AN ORAL AGREEMENT
                   WITH DR. SCOTT, BUT WE BELIEVE MR. HEMINGWAY IS NOT
                   ENTITLED TO THESE PAYMENTS.

              -    FURTHERMORE, MR. HEMINGWAY IS SEEKING TO BE RELEASED
                   FROM A NON-COMPETE CLAUSE IN HIS CONTRACT SO THAT HE
                   -- A COASTAL DIRECTOR WITH A FIDUCIARY OBLIGATION TO
                   ITS SHAREHOLDERS -- CAN COMPETE DIRECTLY WITH
                   COASTAL.

                   DON'T TURN CONTROL OF YOUR COMPANY OVER TO 
                           DR. SCOTT AND HIS NOMINEES.

              We believe Dr. Scott's attempts to mislead you about costs
         are just a means to obscure his true motive -- to regain
         control of the Board.  He seeks to replace Mr. Hatcher, a truly
         independent director, and Mr. Piemont, your Company's CEO, with
         two hand-picked candidates who would join with Dr. Scott and
         the two Scott supporters already on the Board to constitute a
         five director, Scott-controlled majority.

              YOU SHOULD ALSO BE AWARE THAT DR. SCOTT INTENDS TO SEEK
         REIMBURSEMENT -- WITHOUT YOUR APPROVAL -- FOR HIS PROXY CONTEST
         EXPENSES USING SHAREHOLDER FUNDS, WHICH HE CURRENTLY ESTIMATES
         AT $650,000!  THIS IS IN ADDITION TO HIS INSTIGATING COSTLY AND
         SELF-SERVING LITIGATION AGAINST THE COMPANY AND ITS OFFICERS IN
         AN ATTEMPT TO BE REINSTATED AS PRESIDENT AND CHIEF EXECUTIVE
         OFFICER, AS WELL AS COMMENCING AN EXPENSIVE AND DISTRACTING
         PROXY FIGHT TO TRY TO REGAIN CONTROL OF COASTAL.

          YOUR MANAGEMENT'S PLANS FOR MAXIMIZING VALUE FOR SHAREHOLDERS.

              Your management is actively exploring a number of
         strategic options in the course of maximizing Coastal's share
         value.  These include:

         -    selling the entire Company,<PAGE>





         -    disposing of assets which we had not originally planned to
              sell,

         -    or obtaining an investment from strategic or financial
              partners.

              WE ASSURE YOU THAT WE WILL CONTINUE TO AGGRESSIVELY PURSUE
         ALL REASONABLE AND RESPONSIBLE COURSES OF ACTION ON YOUR
         BEHALF.  WE ALSO HOPE SHORTLY TO ANNOUNCE AN ASSET SALE FROM
         WHICH A SUBSTANTIAL PORTION OF THE PROCEEDS RECEIVED WILL BE
         USED TO MEET THE COMPANY'S SHORT-TERM CASH FLOW REQUIREMENTS.

              At our September 27 Annual Meeting, we will be pleased to
         present in more detail the progress we have made in maximizing
         value for the benefit of all Coastal shareholders.  We think
         the choice between your management's nominees and Dr. Scott's
         slate is clear.  DR. SCOTT HAS ALREADY HAD HIS CHANCE TO RUN
         COASTAL AND HIS PERFORMANCE NEARLY BANKRUPTED THE COMPANY.  WHO
         COULD POSSIBLY WANT TO GIVE HIM ANOTHER CHANCE IN LIGHT OF HIS
         SHOCKINGLY POOR RECORD?

               REMEMBER -- ONLY YOUR LATEST DATED PROXY WILL COUNT.

              Please sign, date and return the enclosed WHITE proxy in
         support of your management's candidates for the Board.  Even if
         you have already voted a BLUE Scott proxy, you have every legal
         right to change your mind and vote a WHITE card.

              If you have further questions or need instructions on how
         to vote your shares or to change your vote, please contact
         MacKenzie Partners, Inc., which is assisting us with this
         contest, toll-free at (800) 322-2885.

              We appreciate the continuing support and encouragement we
         have received from shareholders.


         Sincerely yours,

         /s/ Jacque J. Sokolov, M.D.        /s/ Joseph G. Piemont
         JACQUE J. SOKOLOV, M.D.            JOSEPH G. PIEMONT
         Chairman of the Board              President and Chief Executive
                                               Officer


              If you have any questions or need assistance in voting
         your shares or changing your vote, please contact:


                             MACKENZIE PARTNERS, INC.
                                 156 Fifth Avenue
                             New York, New York 10010
                          (212) 929-5500 (Call Collect)
                                        or
                          CALL TOLL-FREE (800) 322-2885


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission